In HIV Vaccine Trial In Thailand, Competing Antibodies May Have Limited The Protection Achieved

Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people. In a study appearing in the journal Proceedings of the National Academy of Sciences, an international team of researchers led by the Duke Human Vaccine Institute describe a previously unknown interaction between antibodies that worked to block the vaccine's protective powers...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: HIV / AIDS Source Type: news